Phospholipid signals and intestinal carcinogenesis

Scandinavian Journal of Food and Nutrition

Volumn 50, Issue SUPPL. 2, 2006, Pages 45-53

  Duan, Rui Dong ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Colon cancer; Inflammatory bowel disease; Phospholipids; Signal transduction pathway; Sphingomyelin; Sphingomyelinase

Indexed keywords

ACYLSPHINGOSINE DEACYLASE; CERAMIDE; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLINOSITOL; PHOSPHOLIPID; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; THROMBOCYTE ACTIVATING FACTOR;

APOPTOSIS; CARCINOGENESIS; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; CONFERENCE PAPER; HUMAN; HYDROLYSIS; INFLAMMATION; INTESTINE CANCER; NONHUMAN; SIGNAL TRANSDUCTION;

EID: 33845892131     PISSN: 17482976     EISSN: 17482984     Source Type: Journal    
DOI: 10.1080/17482970601075703     Document Type: Conference Paper

References (31)

1. Merchant TE, Kasimos JN, de Graaf PW, Minsky BD, Gierke LW, Glonek T. Phospholipid profiles of human colon cancer using 31P magnetic resonance spectroscopy. Int J Colorectal Dis 1991; 6: 121-6.
2. Ikenoue T, Kanai F, Hikiba Y, Obata T, Tanaka Y, Imamura J, et al. Functional analysis of PIK3CA gene mutations in human colorectal cancer. Cancer Res 2005; 65: 4562-7.
3. Roy HK, Olusola BF, Clemens DL, Karolski WJ, Ratashak A, Lynch HT, et al. AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis. Carcinogenesis 2002; 23: 201-5.
4. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996; 87: 803-9.
5. Huls G, Koornstra JJ, Kleibeuker JH. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas. Lancet 2003; 362: 230-2.
6. Nielsen CK, Ohd JF, Wikstrom K, Massoumi R, Paruchuri S, Juhas M, et al. The leukotriene receptor CysLT1 and 5-lipoxygenase are upregulated in colon cancer. Adv Exp Med Biol 2003; 525: 201-4.
7. Ohd JF, Nielsen CK, Campbell J, Landberg G, Lofberg H, Sjolander A. Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas. Gastroenterology 2003; 124: 57-70.
8. Yang M, Zhong WW, Srivastava N, Slavin A, Yang J, Hoey T, et al. G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the β-catenin pathway. Proc Natl Acad Sci USA 2005; 102: 6027-32.
9. Yun CC, Sun H, Wang D, Rusovici R, Castleberry A, Hall RA, et al. LPA2 receptor mediates mitogenic signals in human colon cancer cells. Am J Physiol Cell Physiol 2005; 289: C2-11.
10. Hannun YA, Linardic CM. Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids. Biochim Biophys Acta 1993; 1154: 223-36.
11. Pettus BJ, Chalfant CE, Hannun YA. Ceramide in apoptosis: an overview and current perspectives. Biochim Biophys Acta 2002; 1585: 114-25.
12. Heinrich M, Wickel M, Winoto-Morbach S, Schneider-Brachert W, Weber T, Brunner J, et al. Ceramide as an activator lipid of cathepsin D. Adv Exp Med Biol 2000; 477: 305-15.
13. Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 2003; 4: 397-407.
14. Kawamori T, Osta W, Johnson KR, Pettus BJ, Bielawski J, Tanaka T, et al. Sphingosine kinase 1 is up-regulated in colon carcinogenesis. FASEB J 2006; 20: 386-8.
15. Brasitus TA, Dudeja PK, Dahiya R. Premalignant alterations in the lipid composition and fluidity of colonic brush border membranes of rats administered 1,2 dimethylhydrazine. J Clin Invest 1986; 77: 831-40.
16. Dillehay DL, Webb SK, Schmelz E-M, Merrill AH. Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice. J Nutr 1994; 124: 615-20.
17. Lemonnier LA, Dillehay DL, Vespremi MJ, Abrams J, Brody E, Schmelz EM. Sphingomyelin in the suppression of colon tumors: prevention versus intervention. Arch Biochem Biophys 2003; 419: 129-38.
18. Nilsson Å. The presence of sphingomyelin- and ceramide-cleaving enzymes in the small intestinal tract. Biochim Biophys Acta 1969; 176: 339-47.
19. Duan RD, Bergman T, Xu N, Wu J, Cheng Y, Duan J, et al. Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase family. J Biol Chem 2003; 278: 38528-36.
20. Duan RD. Alkaline sphingomyelinase: an old enzyme with novel implications. Biochim Biophys Acta 2006; 1761: 281-91.
21. Olsson M, Duan RD, Ohlsson L, Nilsson A. Rat intestinal ceramidase: purification, properties, and physiological relevance. Am J Physiol Gastrointest Liver Physiol 2004; 287: G929-37.
22. Hertervig E, Nilsson A, Nyberg L, Duan RD. Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma. Cancer 1997; 79: 448-53.
23. Hertervig E, Nilsson A, Cheng Y, Duan RD. Purified intestinal alkaline sphingomyelinase inhibits proliferation without inducing apoptosis in HT-29 colon carcinoma cells. J Cancer Res Clin Oncol 2003; 129: 577-82.
24. Wu J, Cheng Y, Nilsson A, Duan RD. Identification of one exon deletion of intestinal alkaline sphingomyelinase in colon cancer HT-29 cells and a differentiation-related expression of the wild-type enzyme in Caco-2 cells. Carcinogenesis 2004; 25: 1327-33.
25. Cheng Y, Ohlsson L, Duan RD. Psyllium and fat in diets differentially affect the activities and expressions of colonic sphingomyelinases and caspase in mice. Br J Nutr 2004; 91: 715-23.
26. Wu J, Nilsson A, Jonsson BA, Stenstad H, Agace W, Cheng Y, et al. Intestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activity. Biochem J 2006; 394: 299-308.
27. Cheng Y, Tauschel HD, Nilsson Å, Duan RD. Administration of ursodeoxycholic acid increases the activities of alkaline sphingomyelinase and caspase-3 in rat colon. Scand J Gastroenterol 1999; 34: 915-20.
28. Liu F, Cheng Y, Wu J, Tauschel HD, Duan RD. Ursodeoxycholic acid differentially affects three types of sphingomyelinase in human colon cancer Caco 2 cells. Cancer Lett 2006; 235: 141-6.
29. Andersson D, Nilsson A, Duan R. Ursolic acid and other pentacyclic triterpenoids stimulate intestinal alkaline sphingomyelinase in vitro. Eur J Lipid Sci Technol 2006; 108: 103-8.
30. Liu JJ, Nilsson Å, Duan RD. Effects of phospholipids on sphingomyelin hydrolysis induced by intestinal alkaline sphingomyelinase: an in vitro study. J Nutr Biochem 2000; 11: 192-7.
31. Tepper AD, Ruurs P, Wiedmer T, Sims PJ, Borst J, van Blitterswijk WJ. Sphingomyelin hydrolysis to ceramide during the execution phase of apoptosis results from phospholipid scrambling and alters cell-surface morphology. J Cell Biol 2000; 150: 155-64.